Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replication-defective genomic herpes simplex vectors: design and production.

Edward A Burton1, Qing Bai, William F Goins

  • 1Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.

Current Opinion in Biotechnology
|December 3, 2002
PubMed
Summary

Herpes simplex virus (HSV) can be engineered into gene delivery vectors. Advances in understanding HSV biology and cell entry enable safer, targeted gene therapy applications and scalable vector production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

Nature communications·2026
Same author

Functional interrogation of neuronal connections by chemoptogenetic presynaptic ablation.

Science advances·2026
Same author

Mixed method assesses Chinese rehabilitation students' knowledge, attitude, and practice of physical activity guidelines.

Frontiers in public health·2026
Same author

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Gene therapy·2026
Same author

Advantages of energy restriction approach in mitigating metabolic syndrome: A network meta-analysis.

Nutrition research (New York, N.Y.)·2026
Same author

Water-Soluble Metal Phthalocyanines Enable Molecularly Dispersed Heterogeneous Electrochemical CO<sub>2</sub> Conversion.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Area of Science:

  • Virology
  • Gene Therapy
  • Molecular Biology

Background:

  • Herpes simplex virus (HSV) possesses unique biological features suitable for gene delivery.
  • Lifelong latent infection in the nervous system is a characteristic of HSV.
  • Understanding viral cell entry mechanisms is crucial for targeted gene therapy.

Purpose of the Study:

  • To engineer Herpes simplex virus (HSV) into flexible and efficient gene delivery vectors.
  • To minimize vector toxicity and exploit HSV's natural latency for therapeutic benefit.
  • To enable targeted viral entry into specific cell types for precise gene delivery.

Main Methods:

  • Leveraging increasing understanding of basic HSV biology for vector design.
  • Exploiting viral features responsible for lifelong latent infection.

Related Experiment Videos

  • Investigating viral cell entry mechanisms for targeting strategies.
  • Developing principles for large-scale, pure vector stock production.

    • Main Results:

    • Engineered HSV vectors demonstrate flexibility and efficiency for gene delivery.
    • Minimized vector toxicity and enhanced exploitation of HSV's latent infection capability.
    • Early steps taken towards targeting viral entry to specific cellular subsets.
    • Established sound principles for straightforward, large-scale production of pure vector stocks.

    Conclusions:

    • Herpes simplex virus (HSV) vectors offer a promising platform for gene therapy.
    • Advances in HSV biology and entry mechanisms facilitate safer and more targeted gene delivery.
    • Scalable production methods are established for clinical applications of HSV-based vectors.